284
Views
13
CrossRef citations to date
0
Altmetric
INNER EAR

Astragaloside IV inhibits apoptotic cell death in the guinea pig cochlea exposed to impulse noise

, , &
Pages 467-474 | Received 08 Sep 2011, Accepted 13 Nov 2011, Published online: 04 Jan 2012
 

Abstract

Conclusion: The results suggest that the beneficial effect of astragaloside IV on impulse noise-induced hearing loss may be due to its ability to inhibit reactive oxygen species (ROS) and prevent apoptosis. Objective: Astragaloside IV is the major active constituent of Astragalus membranaceus, which has been widely used for the treatment of diseases in China for its antioxidant properties. ROS and apoptosis are involved in damage induced by impulse noise trauma. We aimed to investigate if the beneficial effects of astragaloside IV on cochlea exposed to impulse noise are associated with the inhibition of ROS and the decrease in apoptosis. Methods: 4-Hydroxynonenal (HNE) was used as the marker of ROS. Active-caspase−3 (cas-3) served as a marker for apoptosis. 4HNE and cas-3 were determined immunohistochemically. Guinea pigs in the experimental group were administered astragaloside IV intragastrically. Auditory thresholds were assessed by sound-evoked auditory brainstem response (ABR) 72 h before and after exposure to impulse noise. Results: The results showed that astragaloside IV significantly reduced ABR deficits, and decreased the expression of ROS and cas-3.

Acknowledgment

This research was supported by Guangdong Traditional Chinese Medicine Research, grant no. 2060123.

Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.